ANI Pharmaceuticals, Inc.
ANIP
$82.10
-$0.57-0.69%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 672.15% | -137.80% | -159.21% | -198.63% | -152.99% |
| Total Depreciation and Amortization | 51.52% | 41.38% | 27.03% | 13.28% | 0.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.27% | 231.32% | 525.94% | 67.38% | -8.53% |
| Change in Net Operating Assets | -30.14% | 120.62% | -97.75% | -144.99% | 190.27% |
| Cash from Operations | 83.77% | 23.58% | -30.28% | -46.19% | 33.05% |
| Capital Expenditure | 7.05% | -4.95% | -27.29% | -83.09% | -65.73% |
| Sale of Property, Plant, and Equipment | -100.00% | -100.00% | -100.00% | -- | -- |
| Cash Acquisitions | 97.91% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -551.96% | -294.88% | -87.66% | 92.56% | 56.19% |
| Cash from Investing | 89.07% | -8,892.53% | -5,899.97% | -2,086.37% | -2,263.50% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 97.89% | -9,853.10% | -9,810.40% | -9,767.70% | -9,787.50% |
| Issuance of Common Stock | 125.93% | -40.18% | -93.01% | -92.75% | -92.35% |
| Repurchase of Common Stock | -9.60% | -6.35% | -21.80% | -119.75% | -123.02% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 3.82% | 0.00% | 0.00% | 0.00% | 0.06% |
| Other Financing Activities | 92.89% | -146.71% | -146.71% | -493.42% | -- |
| Cash from Financing | -103.96% | 1,035.45% | 425.76% | 292.87% | 227.12% |
| Foreign Exchange rate Adjustments | 1,066.67% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 344.75% | -128.41% | -148.97% | -145.40% | -136.47% |